We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $7.06B
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+27.24%
3 Year Est. Return
+83.73%
5 Year Est. Return
+108%
10 Year Est. Return
–
AUM
$7.06B
AUM Growth
+$629M
Cap. Flow
+$148M
Cap. Flow %
2.09%
Top 10 Hldgs %
30.98%
Holding
552
New
36
Increased
171
Reduced
227
Closed
17

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$46.2M
2
TSM icon
TSMC
TSM
+$36.8M
3
RGEN icon
Repligen
RGEN
+$24M
4
NOW icon
ServiceNow
NOW
+$21.3M
5
GE icon
GE Aerospace
GE
+$16M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$30.3M
2
MRSH
Marsh
MRSH
+$14.5M
3
HON icon
Honeywell
HON
+$10.1M
4
SYK icon
Stryker
SYK
+$9.09M
5
ICE icon
Intercontinental Exchange
ICE
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 21.83%
2 Industrials 15.76%
3 Financials 11.61%
4 Healthcare 10.84%
5 Miscellaneous 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AJG icon
376
Arthur J. Gallagher & Co
AJG
$67.3B
$611K 0.01%
2,663
-27
-1% -$5.73K
PPG icon
377
PPG Industries
PPG
$25B
$611K 0.01%
5,040
– –
WRB icon
378
W.R. Berkley
WRB
$25.7B
$611K 0.01%
8,662
-673
-7% -$45.1K
NET icon
379
Cloudflare
NET
$99.3B
$602K 0.01%
+2,455
New +$537K
WPC icon
380
W.P. Carey
WPC
$16B
$602K 0.01%
8,421
+33
+0.4% +$2.42K
DD icon
381
DuPont de Nemours
DD
$17.8B
$600K 0.01%
4,427
-74
-2% -$10.5K
GSK icon
382
GSK
GSK
$100B
$599K 0.01%
11,427
-65
-0.6% -$3.44K
MCHP icon
383
Microchip Technology
MCHP
$40.3B
$594K 0.01%
6,518
-15
-0.2% -$1.34K
TMSL icon
384
T. Rowe Price Small-Mid Cap ETF
TMSL
$2.96B
$594K 0.01%
13,555
+884
+7% +$36.1K
OVV icon
385
Ovintiv
OVV
$17.9B
$589K 0.01%
11,196
+3,533
+46% +$202K
CLX icon
386
Clorox
CLX
$11.3B
$588K 0.01%
+6,165
New +$592K
SLB icon
387
SLB Ltd
SLB
$85.3B
$586K 0.01%
12,608
-13
-0.1% -$697
PYPL icon
388
PayPal
PYPL
$47B
$583K 0.01%
13,496
-770
-5% -$35K
J icon
389
Jacobs Solutions
J
$17.1B
$574K 0.01%
4,553
– –
FOUR icon
390
Shift4
FOUR
$3.63B
$571K 0.01%
11,744
-3,185
-21% -$138K
PLTR icon
391
Palantir
PLTR
$419B
$570K 0.01%
4,883
+518
+12% +$70.7K
IJJ icon
392
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.87B
$569K 0.01%
3,853
-125
-3% -$17.7K
ALL icon
393
Allstate
ALL
$65.6B
$564K 0.01%
2,369
-271
-10% -$58.9K
ULTA icon
394
Ulta Beauty
ULTA
$24.1B
$552K 0.01%
1,225
– –
NDAQ icon
395
Nasdaq
NDAQ
$54.2B
$542K 0.01%
6,880
– –
AGCO icon
396
AGCO
AGCO
$9.34B
$539K 0.01%
4,500
+187
+4% +$21.7K
OHI icon
397
Omega Healthcare
OHI
$14.1B
$538K 0.01%
11,292
-17
-0.2% -$788
ZBH icon
398
Zimmer Biomet
ZBH
$18.7B
$538K 0.01%
6,250
– –
WBS
399
DELISTED
Webster Financial
WBS
$536K 0.01%
7,010
+2,710
+63% +$197K
OPRA
400
Opera Ltd
OPRA
$1.67B
$530K 0.01%
26,729
-2,417
-8% -$42.7K
14 15
16
17 18

Similar funds

EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $7.09B AUM 20.73% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Bradley Foster & Sargent's Q2 2026 Portfolio in Review

As of Q2 2026, Bradley Foster & Sargent held 552 positions worth $7.06B, up 9.8% from $6.44B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q2 2026 filing shows 36 new, 171 increased, 227 reduced and 17 closed positions. Its largest new stake was Repligen: 195,435 shares worth $26.7M. The largest sale was Boston Scientific, an estimated $30.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

  • Bradley Foster & Sargent's largest Q2 2026 buy was Repligen: 195,435 shares worth $26.7M.
  • Bradley Foster & Sargent added most to Danaher in Q2 2026, an estimated $46.2M increase.
  • Bradley Foster & Sargent's biggest Q2 2026 reduction was Boston Scientific, cutting an estimated $30.3M.
  • Bradley Foster & Sargent fully exited Diamondback Energy in Q2 2026, selling an estimated $3.08M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $7.06B portfolio in Q2 2026.
  • Bradley Foster & Sargent opened 36 new positions and closed 17 in Q2 2026.
  • Bradley Foster & Sargent's portfolio value rose 9.8% quarter-over-quarter to $7.06B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.